Literature DB >> 27704464

GL-9 peptide regulates gene expression of CD44 cancer marker and pro-inflammatory cytokine TNF-α in human lung epithelial adenocarcinoma cell line (A549).

Kosar Hooshmand1, Ahmad Asoodeh2,3, Fatemeh Behnam-Rassouli4.   

Abstract

In this study, we examined cytotoxic effect of GL-9 peptide on A459 cell line through studying the changes in TNF-α and CD44 gene expression and ROS production. Real-time PCR analysis showed that the treated A549 cells highly over expressed TNF-α, which was associated with a significant reduction of CD44 gene expression levels (p  <  0.05). ROS production rate was measured through the usage of DCFH-DA primer. Results demonstrated that GL-9 peptide could also induce cell death via ROS production. The effect of GL-9 peptide on human erythrocytes and leukocytes was analyzed. GL-9 peptide showed no significant toxic effect on human blood cells. Our results suggested that the GL-9 peptide as a potent natural agent could modulate gene expression of cancer cell markers.

Entities:  

Keywords:  Blood cells; Cell death; Peptide; Real-time polymerase chain reaction; Tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2016        PMID: 27704464     DOI: 10.1007/s11010-016-2832-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Novel method to identify the optimal antimicrobial peptide in a combination matrix, using anoplin as an example.

Authors:  J K Munk; C Ritz; F P Fliedner; N Frimodt-Møller; P R Hansen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

2.  Effects of hyperbaric oxygen in circulatory shock induced by splanchnic artery occlusion and reperfusion in rats.

Authors:  H Bitterman; N Bitterman; Y Melamed; L Cohen
Journal:  Can J Physiol Pharmacol       Date:  1989-09       Impact factor: 2.273

3.  Effect of D-amino acid substitutions on Ni(II)-assisted peptide bond hydrolysis.

Authors:  Hanieh H Ariani; Agnieszka Polkowska-Nowakowska; Wojciech Bal
Journal:  Inorg Chem       Date:  2013-02-21       Impact factor: 5.165

4.  Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.

Authors:  Neelakandan Muthukumaran; Karl E Miletti-González; Abhilash K Ravindranath; Lorna Rodríguez-Rodríguez
Journal:  Mol Cancer Res       Date:  2006-08       Impact factor: 5.852

5.  In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.

Authors:  Sunkyu Kim; Sukwon S Kim; Yung Jue Bang; Seong Jin Kim; Byeong Jae Lee
Journal:  Peptides       Date:  2003-07       Impact factor: 3.750

6.  TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.

Authors:  Michal Barshishat; Amiram Ariel; Liora Cahalon; Yehuda Chowers; Ofer Lider; Betty Schwartz
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.

Authors:  Sonia Aroui; Souhir Brahim; Michel De Waard; Abderraouf Kenani
Journal:  Biochem Biophys Res Commun       Date:  2009-11-13       Impact factor: 3.575

Review 8.  Peptide-based cancer therapy: opportunity and challenge.

Authors:  Dongdong Wu; Yanfeng Gao; Yuanming Qi; Lixiang Chen; Yuanfang Ma; Yanzhang Li
Journal:  Cancer Lett       Date:  2014-05-13       Impact factor: 8.679

9.  Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms.

Authors:  Dharmendra K Maurya; Nivedita Nandakumar; Thomas Paul Asir Devasagayam
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

10.  Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Authors:  Elaine Lai-Han Leung; Ronald R Fiscus; James W Tung; Vicky Pui-Chi Tin; Lik Cheung Cheng; Alan Dart-Loon Sihoe; Louis M Fink; Yupo Ma; Maria Pik Wong
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more
  1 in total

1.  TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling.

Authors:  Li Ma; Chunhua She; Qian Shi; Qiang Yin; Xinxin Ji; Yongrong Wang; Yulong Fan; Xinyao Kong; Peng Li; Zengfeng Sun; Xiaohui Zhang; Zhen Zhang; Jian Wang; Tong Wang; Yuanfu Xu; Wenliang Li
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.